160 related articles for article (PubMed ID: 38215178)
21. Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.
Kant A; de Vries L; Rolfes L
Drug Saf; 2019 Jan; 42(1):35-43. PubMed ID: 30284215
[TBL] [Abstract][Full Text] [Related]
22. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.
Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL
Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091
[TBL] [Abstract][Full Text] [Related]
23. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
[TBL] [Abstract][Full Text] [Related]
24. Pharmacovigilance in children in Camagüey Province, Cuba.
Bárzaga Arencibia Z; López Leyva A; Mejías Peña Y; González Reyes AR; Fernández Manzano E; Choonara I
Eur J Clin Pharmacol; 2012 Jul; 68(7):1079-84. PubMed ID: 22315149
[TBL] [Abstract][Full Text] [Related]
25. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
[TBL] [Abstract][Full Text] [Related]
26. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
27. Pharmacovigilance practice among pediatric neurologists from Poland and Germany.
Kopciuch D; Kus K; Niśkiewicz I; Fliciński J; Zaprutko T; Ratajczak P; Nowakowska E; Hoffmann K; Koligat-Seitz A; Bryl W; Paczkowska A
BMC Med Educ; 2023 Aug; 23(1):547. PubMed ID: 37528387
[TBL] [Abstract][Full Text] [Related]
28. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992].
Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
Therapie; 1994; 49(2):123-7. PubMed ID: 7817335
[TBL] [Abstract][Full Text] [Related]
30. A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.
Mokbel K; Daniels R; Weedon MN; Jackson L
In Vivo; 2022; 36(2):780-800. PubMed ID: 35241534
[TBL] [Abstract][Full Text] [Related]
31. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A
BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
33. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
[TBL] [Abstract][Full Text] [Related]
34. Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview.
Singh P; Vaishnav Y; Verma S
Curr Drug Saf; 2023; 18(4):448-464. PubMed ID: 36200243
[TBL] [Abstract][Full Text] [Related]
35. Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.
Zondi S; Naidoo P
BMC Health Serv Res; 2022 Aug; 22(1):1054. PubMed ID: 35982442
[TBL] [Abstract][Full Text] [Related]
36. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
[TBL] [Abstract][Full Text] [Related]
37. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
[TBL] [Abstract][Full Text] [Related]
38. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
[TBL] [Abstract][Full Text] [Related]
39. A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation.
Lee S; Lee JH; Kim GJ; Kim JY; Shin H; Ko I; Choe S; Kim JH
J Med Internet Res; 2022 Oct; 24(10):e35464. PubMed ID: 36201386
[TBL] [Abstract][Full Text] [Related]
40. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
